comparemela.com

Latest Breaking News On - Lepu holdings - Page 1 : comparemela.com

Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Inspirna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Rockefeller-university
New-york
United-states
Alexandria
Al-iskandariyah
Egypt
Usman-oz-azam
Alexandria-venture-investments
Novo-holdings
Lepu-holdings
Silicon-valley-bank
Wuxi-pharmatech-healthcare-fund

Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023

Inspirna to Present Clinical Data from Phase 1b/2 Study of Ompenaclid (RGX-202) in Advanced Colorectal Cancer at ESMO Congress 2023
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Madrid
Spain
New-york
United-states
Rockefeller-university
Alexandria
Al-iskandariyah
Egypt
Andrew-hendifar
Product-service
Bristol-myers-squibb
Novo-holdings

Inspirna Raises $50 Million in Series D Financing

Inspirna Raises $50 Million in Series D Financing
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
California
Virginia
Rockefeller-university
Alexandria
Al-iskandariyah
Egypt
Palo-alto
American
Michael-ginder
Jack-nielsen

Inspirna Raises $50M in Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

New-york
United-states
Michael-ginder
Jack-nielsen
Masoud-tavazoie
Sixty-degree-capital-fund
York-city-investment-fund
Lepu-holdings
Novo-holdings
New-york-based
Sands-capital
Vivo-capital

Inspirna, Inc.: Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 ESMO World Congress on Gastrointestinal Cancer

Favorable efficacy and safety support further development of RGX-202-01 in advanced or metastatic second-line colorectal cancer Inspirna, Inc., a clinical stage biopharmaceutical company developing

New-york
United-states
Alexandria
Al-iskandariyah
Egypt
Rockefeller-university
Spain
Barcelona
Comunidad-autonoma-de-cataluna
Kostenloser-wertpapierhandel
Maeve-conneighton
Andrew-hendifar

vimarsana © 2020. All Rights Reserved.